Aortic arch catheterization during transfemoral carotid artery stenting: an underestimated source of cerebral emboli

G Palombo1, N Stella, V Faraglia

  • 1Department of Vascular Surgery, Sant'Andrea Hospital, La Sapienza University of Rome (Second Medical School), Rome, Italy. giovanni.palombo@tiscali.it

Insights

Cerebral embolization during carotid artery stenting is a concern. Transcervical access, using carotid artery stenting (CAS), may reduce embolic load, as supported by transcranial Doppler (TCD) and diffusion-weighted magnetic resonance imaging (DW-MRI) data.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Medical Imaging

Background:

  • Cerebral embolization is a significant risk for patients undergoing transfemoral carotid artery stenting (CAS).
  • Current monitoring techniques like transcranial Doppler (TCD) and diffusion-weighted magnetic resonance imaging (DW-MRI) highlight the impact of aortic arch catheterization on embolic load.
  • Transcervical access (surgical or percutaneous) has been proposed as an alternative to reduce cerebral embolization during CAS.

Purpose of the Study:

  • To review existing transcranial Doppler (TCD) and diffusion-weighted magnetic resonance imaging (DW-MRI) data.
  • To evaluate the evidence supporting transcervical carotid artery stenting (CAS) as a method to reduce cerebral embolization.
  • To present the clinical outcomes associated with transcervical CAS.

Main Methods:

  • Literature review of studies utilizing TCD and DW-MRI for embolic load assessment during CAS.
  • Analysis of data comparing transfemoral CAS with transcervical CAS approaches.
  • Compilation and review of clinical results from transcervical CAS procedures.

Main Results:

  • TCD and DW-MRI data suggest that aortic arch catheterization contributes to the embolic burden during transfemoral CAS.
  • Evidence indicates that transcervical access may mitigate the risk of cerebral embolization compared to the transfemoral approach.
  • Clinical results for transcervical CAS are presented, offering insights into its efficacy and safety.

Conclusions:

  • Transcervical access for carotid artery stenting (CAS) shows promise in reducing cerebral embolization.
  • TCD and DW-MRI data provide a basis for considering transcervical CAS as a safer alternative.
  • Further investigation into the clinical outcomes of transcervical CAS is warranted.